A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer’s disease, Parkinson’s disease, and related conditions, creating potential for a unified treatment approach for major neurological diseases, led by researchers from NYU School of Medicine.

See the source article by following the link below:
A new kind of antibody targets a feature shared by proteins thought to cause the most damage in Alzheimer’s disease, Parkinson’s disease, and related conditions, creating potential for a unified treatment approach for major neurological diseases, led by researchers from NYU School of Medicine.